We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

334 hedge funds and large institutions have $7.13B invested in United Therapeutics in 2014 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 93 increasing their positions, 147 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

5% more funds holding

Funds holding: 319 → 334 (+15)

5% more capital invested

Capital invested by funds: $6.8B → $7.13B (+$336M)

4% more call options, than puts

Call options by funds: $39.2M | Put options by funds: $37.8M

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

37% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 147

Holders
334
Holders Change
+15
Holders Change %
+4.7%
% of All Funds
8.91%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
54
Increased
93
Reduced
147
Closed
36
Calls
$39.2M
Puts
$37.8M
Net Calls
+$1.37M
Net Calls Change
+$239M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$41.6M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$41.6M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$32.3M
4
IAM
Iridian Asset Management
Connecticut
+$30.4M
5
First Trust Advisors
First Trust Advisors
Illinois
+$27.1M

Top Sellers

1
HCM
Herndon Capital Management
Georgia
-$145M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$87.6M
3
WG
Winton Group
United Kingdom
-$48.4M
4
AL
AJO LP
Pennsylvania
-$39.3M
5
Los Angeles Capital Management
Los Angeles Capital Management
California
-$32.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$57.3M -$12.1M -93,521 -17%
Norges Bank
27
Norges Bank
Norway
$55.2M +$3.97M +30,835 +8%
Allianz Asset Management
28
Allianz Asset Management
Germany
$54.8M -$12.9M -100,215 -19%
Invesco
29
Invesco
Georgia
$51.2M +$25.5M +198,109 +100%
RFC
30
Russell Frank Company
Washington
$48.7M -$590K -4,575 -1%
First Eagle Investment Management
31
First Eagle Investment Management
New York
$46.6M +$12.6M +98,100 +37%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$42.5M +$1.57M +12,210 +4%
Morgan Stanley
33
Morgan Stanley
New York
$42.3M +$11.5M +89,203 +38%
GAM
34
Gotham Asset Management
New York
$41.8M +$4.47M +34,687 +12%
Goldman Sachs
35
Goldman Sachs
New York
$37.4M -$5.18M -40,168 -12%
Marshall Wace
36
Marshall Wace
United Kingdom
$35.2M +$26.1M +202,820 +293%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$34.7M +$8.44M +65,527 +38%
Prudential Financial
38
Prudential Financial
New Jersey
$34M -$1.31M -10,180 -4%
SGAM
39
Smith Group Asset Management
Texas
$33.8M +$24.5K +190 +0.1%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$32.4M +$32.3M +250,442 New
GT
41
Glenmede Trust
Pennsylvania
$32.4M +$1.48M +11,448 +5%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$31.8M -$21.2M -164,400 -40%
CCI
43
Columbus Circle Investors
$31.4M +$19.4M +150,712 +164%
GC
44
Guggenheim Capital
Illinois
$29.7M -$5.94M -46,100 -17%
JP Morgan Chase
45
JP Morgan Chase
New York
$26.9M -$16.1M -125,114 -38%
RCAMU
46
Rothschild & Co Asset Management US
Connecticut
$26M +$14.3M +111,108 +125%
BlackRock
47
BlackRock
New York
$24.8M +$5.63M +43,707 +30%
Renaissance Technologies
48
Renaissance Technologies
New York
$24M +$23.6M +182,860 +7,690%
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$23.6M -$202K -1,565 -0.9%
Wells Fargo
50
Wells Fargo
California
$23.3M -$1.34M -10,366 -5%
1
2
3 4 5

UTHR Hedge Fund Activity: Q4 2014 in Review

334 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2014, worth a combined $7.13B — up 4.9% from $6.8B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new UTHR positions and 36 closed out — a net gain of 18 holders — while 93 added to existing stakes and 147 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $41.6M. The largest seller was Herndon Capital Management, cutting an estimated $145M.

  • 334 institutional investors held United Therapeutics (UTHR) as of Q4 2014, up from 319 in Q3 2014.
  • Funds reported $7.13B of United Therapeutics stock for Q4 2014, up 4.9% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q4 2014 and 36 closed out, a net change of +18 holders.
  • The largest United Therapeutics buyer in Q4 2014 was Scopia Capital Management, an estimated $41.6M added.
  • The largest United Therapeutics seller in Q4 2014 was Herndon Capital Management, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2014.